You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Dynamic Frequency Passive Millimeter-Wave Radiometer Based on Optical Up-Conversion
SBC: PHASE SENSITIVE INNOVATIONS INC Topic: 941DIn the proposed effort, we will leverage this extensive experience and capabilities to realize a frequency agile mmW radiometer that can cover the range of DC-110 GHz and can be scaled to DC-200 GHz under Phase II. Ours is a photonic system that multiplies and up-coverts a low-frequency reference signal onto an optical carrier (laser) using EO modulation, then uses the modulation sidebands to inj ...
SBIR Phase I 2013 Department of CommerceNational Oceanic and Atmospheric Administration -
Developing a Standard Integrated Framework for Transit Assest Management Information
SBC: Encada LLC Topic: 131FT2Transit Agency Information required for managing Service centers on resources and assets that need to be available to operate the transit service as designed. An opportunity exists to design an Integrated Framework providing Service delivery and Maintenance Management Information to quantify the reliability and availability of the assets. This framework will incorporate modeling of the asset inven ...
SBIR Phase I 2013 Department of Transportation -
Nicotine delivery to rodent with lung alveolar region-targeted aerosol technology
SBC: STARSHIP HEALTH TECHNOLOGIES LLC Topic: NIADESCRIPTION (provided by applicant): The C-PACE Project (Communications Processes for Accountable Care Enhancement) will develop a new and innovative form of social computing that is customized for the care of frail, elderly patients. A successful C-PACE system will improve patient-centered health care, reduce medical errors, and provide the kind of data that CMS, third party payers, Accountable C ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Mitigation of Radiation-Induced Pulmonary Fibrosis by a Sphingosine Kinase Inhibi
SBC: Apogee Biotechnology Corporation Topic: NIAIDDESCRIPTION (provided by applicant): Radiation-induced production of pro-inflammatory and pro-fibrotic cytokines results in chronic and irreversible damage to the lungs. To date, no agent has demonstrated a sufficient safety profile to be utilized as a clinical drug for mitigating damage from exposure to radiation from accidental or terroristic nuclear events. Consequently, there is a great need ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Development of Fluorinated Sulfamoylbenzamide Derivatives as Antiviral Agents aga
SBC: Enantigen Therapeutics Topic: NIAIDDESCRIPTION (provided by applicant): This is a phase I proposal to determine the feasibility of developing newly discovered fluorinated sulfamoylbenzamide (FSBA) derivatives as therapeutic agents for the treatment of chronic hepatitis B virus (HBV) infection. These molecules have been identified as inhibitors of HBV pregenomic (pg) RNA encapsidation, which is essential for the subsequent viral DNA ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Neural Probe for high spatial and temporal resolution detection of cocaine and su
SBC: Enantigen Therapeutics Topic: NIAIDDESCRIPTION (provided by applicant): This is a proposal to implement a novel high throughput assay system to detect inhibitors of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) formation and/or maintenance. HBV cccDNA is essential to the virus life cycle and its elimination during chronic infection is considered critical to durable therapy. However, because of the limitations of c ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Biofidelic Slip-Testing Device for Measuring and Analyzing Shoe-Floor Friction
SBC: CROSSROADS CONSULTING LLC Topic: NIAMSDESCRIPTION (provided by applicant): Falling accidents are among the largest and fastest growing sources of occupational injuries. Despite slips representing a plurality of all falling accidents, the technology used to assess the slipperiness of shoe andfloor surfaces has remained relatively stagnant over the past two decades. A major limitation in existing slip-testers is that the under-shoe co ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Semi-targeted Immuno-Therapeutic Approach for Treatment of Obesity
SBC: Diffregen, Inc. Topic: NCIDESCRIPTION (provided by applicant): This Phase 1 SBIR project is to perform go-/no-go evaluation of the proprietary protein, angiocidin, as a novel therapy for the treatment of acute myeloid leukemia (AML). AML is a significant medical burden as existingtherapy based on cytotoxic drugs has a low efficacy rate and is contraindicated in many elderly people, who comprise the largest and fastest grow ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Diet Assessment Communications Portal for Data Sharing within the PCMN
SBC: COMMUNITY STRATEGIES Topic: NIDADESCRIPTION (provided by applicant): The central goal of the proposed project is to assess the feasibility of a commercially viable, preventive intervention product aimed at enhancing new fathers' positive adaptation to parenthood. We will integrate an existing evidence-based transition to parenthood program with leading fatherhood promotion curriculum materials, and deliver the intervention ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Treating type 2 diabetes with menin inhibitors
SBC: NOVAPEUTICS, LLC Topic: NIDDKDESCRIPTION (provided by applicant): One of the hallmarks of type 2 diabetes (T2D) is an inadequate number of functional pancreatic beta cells that results in insufficient insulin leading to hyperglycemia. Our preliminary work using various mouse models identified a novel target, menin, which can be modulated to stimulate beta cell regeneration and reverse established hyperglycemia in diabetic mic ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health